Mustang Bio Inc

Financials

Cash from operating activities 1.76 M2 M1.39 M1.34 M818 K 5.54 M Cash from investing activities 001.17 M00 1.17 M Cash from financing activities 1.01 M4.94 M7.62 M-235 K7.14 M 19.46 M Free cash flow 1.76 M2 M1.39 M1.34 M818 K 5.54 M

Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency.

Nouvelles

MBIO

Financials

Mustang Bio Inc

Nouvelles

L’action de Fortress Biotech chute suite à une lettre de réponse complète de la FDA pour CUTX-101

Fortress Biotech stock price target lowered to $17 at H.C. Wainwright

Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On - Calidi Biotherapeutics (AMEX:CLDI), Mustang Bio (NASDAQ:MBIO)

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.94%

Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation - Mustang Bio (NASDAQ:MBIO)

Dow Dips 1%; Mustang Bio Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Artelo Biosciences (NASDAQ:ARTL)

Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS - Blue Gold (NASDAQ:BGL), Artelo Biosciences (NASDAQ:ARTL)

Mustang Bio stock soars after FDA grants orphan drug designation

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.02%

US Stocks Mixed; UniFirst Shares Fall After Q3 Results - BioNexus Gene Lab (NASDAQ:BGLC), Blue Gold (NASDAQ:BGL)

Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Argo Blockchain (NASDAQ:ARBK)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.91%